0 CHECKOUT

PRODUCT FILTERS

REGION

4
2
2
2
1

COUNTRY

2
1

CATEGORIES

  • 5
  • 5
  • 2
  • 1
  • 1

PRICE

10
10
10
13

PUBLISHED

0
3
7
13

PRODUCT TYPE

6
3
2
1
1

Search for: "Salix Pharmaceuticals, Ltd.-Deals & Alliances Report"

13 Products

Salix Pharmaceuticals, Ltd. - Strategy and SWOT Report

Salix Pharmaceuticals, Ltd. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service...

Published:  September 2014
Price:  From

Salix Pharmaceuticals, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

Published:  May 2015
Price:  From

Salix Pharmaceuticals Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review

Salix Pharmaceuticals Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  April 2015
Price:  From

Salix Pharmaceuticals, Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review

Salix Pharmaceuticals, Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review Summary Salix Pharmaceuticals, Ltd. (Salix) is a specialty pharmaceutical company focusing on licensing, developing...

Published:  September 2011
Price:  From

Inflammatory Bowel Disease Therapeutics - Global Strategic Business Report

This report analyzes the Global market for Inflammatory Bowel Disease Therapeutics in US$ Million Annual estimates and forecasts are provided for the period 2006 through 2015 The report profiles 69...

Published:  April 2010
Price:  From

Prescription Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class – Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors,...

Published:  July 2009
Price:  From

Global Biosimilars Market, 2015 - 2025

Characterised by increased utility in chronic diseases and capital intensive manufacturing, the global biopharmaceutical market is expanding robustly. As the demand for biologics is increasing continuously,...

Published:  July 2015
Price:  From

Eisai Inc. - Strategic SWOT Analysis Review

Eisai Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,...

Published:  June 2015
Price:  From

Santarus, Inc. (SNTS) - Financial and Strategic SWOT Analysis Review

Summary Santarus, Inc. (Santarus) is a specialty biopharmaceutical company. It acquires, develops and commercializing pharmaceutical products. The company’s marketed products consists of Uceris (budesonide)...

Published:  March 2013
Price:  From

Pharmos Corporation (PARS) - Financial and Strategic SWOT Analysis Review

Pharmos Corporation (PARS) - Financial and Strategic SWOT Analysis Review Summary Pharmos Corporation (Pharmos) is a biopharmaceutical company, principally engaged in the discovery and development...

Published:  September 2011
Price:  From

Eisai Co., Ltd. - Product Pipeline Review - H2 2011

Eisai Co., Ltd. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Eisai Co., Ltd. - Product Pipeline Review - H2 2011” provides data on the Eisai Co., Ltd.’s...

Published:  November 2011
Price:  From

North American Corporate Rating Scores By Industry Sector As Of March 5, 2015 May 15

Abstract Standard & Poor's Ratings Services is updating the rating component scores for its public corporate credit ratings in North America. This article follows a similar report published on Feb....

Published:  May 2015
Price: 

Global Corporate Debt Demand Declines To $57 Trillion As Credit Risk Concentrates In China, U.S. Jul 15

Abstract MELBOURNE (Standard & Poor's) July 16, 2015--Global corporate debt demand will peak at an estimated $57 trillion by 2019, a decline of 4% from last year's projection, according to an annual...

Published:  July 2015
Price: 
Loading Indicator

Our Clients

  • Intel Corporation
  • Autodesk, Inc.
  • Hewlett-Packard Company
  • Ahlstrom Corporation
  • SAP SE
  • 3M Company
  • Samsung Group Ltd.